Insights

Get in Touch

Our Locations

High Throughput ADME

Minimizing turnaround time for ADME assays is key to managing costs during drug development. Automation is essential for high throughput ADME screening to help deliver data quickly.

Automation is essential for high throughput ADME screening. Beyond conducting the assays, automation touches every step of the process to help deliver data quickly. Automation is used on the back end for bioanalysis on a variety of analytical instruments. Bioanalysis is typically done by LC-MS or liquid chromatography-mass spectrometry.

Download our insight brief today.

Authored by J. Matthew Hutzler, Ph.D., Site Director, ADME Services

Complete the form below to access this insight brief

Related Services & Solutions

Related Thought Leaders Insights

Scientific Poster

Robust performance of single-cell multiomic analysis (CITE-Seq) demonstrated across multiple locations, replicates, and donors on challenging cryopreserved PBMC and BMMC samples

Q² Solutions is the first and only service provider to achieve the exclusive certified service partnership for CITE-Seq scRNA-Seq with BioLegend. Describes CITE-Seq performance expectations for...

Brochure

Challenging Bioanalytical Work

If you’re looking for solutions to analytical challenges, you’ve come to the right place. Our highly trained scientists partner with you to provide a well-planned strategy, no matter where you are in...

Factsheet

CNS Biomarkers

Rules-Based Medicine, a Q² Solutions company, offers ultrasensitive immunoassays – including beta-amyloids, GFAP, NF-L, and pTaus – for the development of diagnostics and therapeutics for Alzheimer’s...